McDonnell DP - Search Results

1

CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.

Racioppi L, Nelson ER, Huang W, Mukherjee D, Lawrence SA, Lento W, Masci AM, Jiao Y, Park S, York B, Liu Y, Baek AE, Drewry DH, Zuercher WJ, Bertani FR, Businaro L, Geradts J, Hall A, Means AR, Chao N, Chang CY, McDonnell DP. Racioppi L, et al. Among authors: mcdonnell dp. Nat Commun. 2019 Jun 4;10(1):2450. doi: 10.1038/s41467-019-10424-5. Nat Commun. 2019. PMID: 31164648 Free PMC article.

2

Peptide antagonists of the human estrogen receptor.

Norris JD, Paige LA, Christensen DJ, Chang CY, Huacani MR, Fan D, Hamilton PT, Fowlkes DM, McDonnell DP. Norris JD, et al. Among authors: mcdonnell dp. Science. 1999 Jul 30;285(5428):744-6. doi: 10.1126/science.285.5428.744. Science. 1999. PMID: 10426998

3

Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.

Chang Cy, Norris JD, Grøn H, Paige LA, Hamilton PT, Kenan DJ, Fowlkes D, McDonnell DP. Chang Cy, et al. Among authors: mcdonnell dp. Mol Cell Biol. 1999 Dec;19(12):8226-39. doi: 10.1128/MCB.19.12.8226. Mol Cell Biol. 1999. PMID: 10567548 Free PMC article.

4

Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.

Hall JM, Chang CY, McDonnell DP. Hall JM, et al. Among authors: mcdonnell dp. Mol Endocrinol. 2000 Dec;14(12):2010-23. doi: 10.1210/mend.14.12.0561. Mol Endocrinol. 2000. PMID: 11117531

5

Development of peptide antagonists that target estrogen receptor-cofactor interactions.

McDonnell DP, Chang CY, Norris JD. McDonnell DP, et al. J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):327-35. doi: 10.1016/s0960-0760(00)00109-6. J Steroid Biochem Mol Biol. 2000. PMID: 11162941 Review.

6

Estrogen receptor-cofactor interactions as targets for novel drug discovery.

Norris JD, Chang C, McDonnell DP. Norris JD, et al. Among authors: mcdonnell dp. Ernst Schering Res Found Workshop. 2001;(34):181-201. doi: 10.1007/978-3-662-04645-6_10. Ernst Schering Res Found Workshop. 2001. PMID: 11394045 Review. No abstract available.

7

Glucocorticoids manifest androgenic activity in a cell line derived from a metastatic prostate cancer.

Chang CY, Walther PJ, McDonnell DP. Chang CY, et al. Among authors: mcdonnell dp. Cancer Res. 2001 Dec 15;61(24):8712-7. Cancer Res. 2001. PMID: 11751389

8

Capitalizing on the complexities of estrogen receptor pharmacology in the quest for the perfect SERM.

McDonnell DP, Chang CY, Norris JD. McDonnell DP, et al. Ann N Y Acad Sci. 2001 Dec;949:16-35. doi: 10.1111/j.1749-6632.2001.tb03999.x. Ann N Y Acad Sci. 2001. PMID: 11795348

9

Evaluation of ligand-dependent changes in AR structure using peptide probes.

Chang CY, McDonnell DP. Chang CY, et al. Among authors: mcdonnell dp. Mol Endocrinol. 2002 Apr;16(4):647-60. doi: 10.1210/mend.16.4.0818. Mol Endocrinol. 2002. PMID: 11923463

10

Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators.

McDonnell DP, Connor CE, Wijayaratne A, Chang CY, Norris JD. McDonnell DP, et al. Recent Prog Horm Res. 2002;57:295-316. doi: 10.1210/rp.57.1.295. Recent Prog Horm Res. 2002. PMID: 12017549 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters